MaaT Pharma Announces First Patient Randomized in IMMUNOLIFE Phase 2 Study Sponsored by Gustave Roussy,…
MaaT PharmaJanuary 20, 2026
MaaT Pharma Publishes its Half Year 2025 Results and Provides a Business Update Positive results…
MaaT PharmaSeptember 17, 2025
MaaT Pharma To Present Updated Data for MaaT013 in Early Access Program at the European…
MaaT PharmaMay 14, 2025
MaaT Pharma Announces Promising Final Data Readout for Phase 1b Evaluating MaaT033 in Amyotrophic Lateral…
MaaT PharmaMay 12, 2025
MaaT Pharma Announces First DSMB Positive Review of Ongoing Phase 2 Clinical Trial Evaluating MaaT033…
MaaT PharmaJuly 2, 2024
MaaT Pharma Announces Positive Review from the DSMB on the Ongoing Phase 1 Clinical Trial…
MaaT PharmaFebruary 29, 2024
